Form 4 for OGN Organon & Co.

Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-01 · accession 0001104659-22-055427 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-05-03	2022-05-01	OGN	Falcione Aaron	CHRO	F - Tax	$32.33	-418	4,170	-9%	-$13.5K
D	2022-05-03	2022-05-01	OGN	Falcione Aaron	CHRO	M - OptEx	—	+1,219	4,588	+36%	—
D	2022-05-03	2022-05-01	OGN	Falcione Aaron	CHRO	M - OptEx	$0.00	-1,219	1,219	-50%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-01	F	D	418	$32.33	4,170	D	—	—
2	Common	Common Stock	2022-05-01	M	A	1,219	—	4,588	D	—	—	(F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023.
3	Derivative	Restricted Stock Units	2022-05-01	M	D	1,219	$0.00	1,219	D	— · 2022-05-01 to 2023-05-01	1,219 Common Stock	(F2) The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023.